Open to PhD applications in the field of
- Characterisation of a molecular group in solid cancers that represents an innate immune response to DNA damage through the STING pathway.
- Development of a gene expression based biomarker panel that can identify pathways related to the hallmarks of cancer and guide patient therapy.
Public outreach & key achievements
- Nuala is responsible for the discovery and development of biomarkers for clinical trials and run a joint research programme between QUB and Almac.
|PhD Title||Consensus subtyping of Prostrate Cancer|